I'm happy to address that. If Paul-Émile wants to add anything else, he can certainly do so.
Our hospital research institute at UHN will be one of the recipients of those funds. The $450 million from the federal government that was announced last Friday is there to support the wages of our staff who have been impacted by COVID-19. Like many businesses across Canada, non-COVID-related research was largely suspended across the world.
At our institution, over 80% of our research was suspended to prepare for COVID-19 and to change the way that we deliver care in the hospital. This led to an immediate loss of revenue for us from all of the external sponsors of our research, the pharmaceutical companies and biotech companies that fund clinical trials. At our institute alone, that clinical trial revenue supported over 700 jobs.
We were very close to having over 1,500 job layoffs in research at UHN. This was largely due to the fact that we were ineligible for the wage subsidy program that was created by the federal government for this purpose, largely due to a technicality. That technicality is that we're part of a public hospital that is ineligible for the funding, despite the fact that none of our funding for research comes from the provincial government or the Ministry of Health. We're not allowed to use any of those funds for research.
We were kind of stuck, and the only options available to us were to lay off staff so that they could collect the emergency response benefit, the funds that were talked about here, but this funding that has come in really at the last moment for us is going to allow us to preserve those jobs, to prepare for the restart of research and also to support the critical COVID-related research that is still occurring and is very active at our institution and at many others like ours across the country.